| EMA number | EMEA/H/C/004101 |
| ATC code | A10AE04 |
| Authorisation | 3 January 2017 |
| Withdrawn | 29 October 2018 |
| Revision | 2 |
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
TOUJEO — SANOFI US SERVICES, approved 2024-08-29 (BLA206538).
159,088 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.